How to stop COVID, and maybe whatever comes next
By GREGORY ZELLER // The latest DNA-based advance by a progressive Long Island biotech goes where other biochemists have gone before – but also blazes a trail for new vaccination…
biotechnology
Familiar face takes the reins at FSC’s Bioscience Park
By GREGORY ZELLER // Broad Hollow Bioscience Park’s new head honcho is an old friend of regional commercialization. Dan Polner, most recently the incubator advocate for Stony Brook University’s Office…
With Nassau in the PILOT seat, Acupath thinks bigger
By GREGORY ZELLER // A veteran Long Island biotech that found new footing during the COVID crisis is on the verge of a major expansion, with a tip of the…
LI biotech gears up to help shoot down forced labor
By GREGORY ZELLER // A new federal law governing Chinese imports bodes very well for a leading Long Island innovator. Stony Brook-based Applied DNA Sciences – a DNA-based supply-chain authenticator that’s…
For Broad Hollow Bioscience Park, a beauty of a deal
By GREGORY ZELLER // A major-league anchor tenant will breathe new life into Broad Hollow Bioscience Park. The not-for-profit facility on the Farmingdale State College campus, designed primarily to support…
SBU joins SUNY Buffalo as Flagship Public University
By GREGORY ZELLER // Stony Brook University has joined The University at Buffalo to split a rare distinction: They now share the mantle as New York State Flagship Public Universities….
Albany pumps $40M into biotech commercialization
By GREGORY ZELLER // Good news for Long Island’s impressive biotech-research corridor: New York State has opened a new Biodefense Commercialization Fund designed to speed promising life-science research to market….
New collaboration gives Acupath wings, literally
By GREGORY ZELLER // Despite the lingering threat of COVID-19, Acupath has announced a world tour. Actually, the tour is because of that lingering threat. Acupath Laboratories, the Plainview-based diagnostics…
Despite innovations, LI wasn’t always a biotech hotbed
By TOM MARINER // Long Island is recognized as a burgeoning biotech corridor now, though its past biotech efforts “flied under the radar” – despite the region giving birth to…
Small screen, big honor for Emmy-nominated series
By GREGORY ZELLER // And the Emmy Award nominations go to … HJMT Public Relations! Whether the Long Beach-based PR house walks away with a golden statuette remains to be…
New collaboration cuts to the heart of RNA splicing
By GREGORY ZELLER // A Cold Spring Harbor Laboratory spinoff and a Massachusetts-based neuroscience trailblazer are teaming up to advance ribonucleic acid splicing research – key to addressing several central…
Large buy-in has DepYmed eyeing huge clinical trials
By GREGORY ZELLER // Farmingdale pharmaceutical firm DepYmed is no stranger to capital investments – but a new infusion might be enough to push the rare-disease innovator over the commercialization…
‘Harvestable energy’ fuels second CEBIP graduate
By GREGORY ZELLER // A waste-not biotech with a true sense of sustainability has become the second company to graduate from the Clean Energy Business Incubator Program, despite logistical challenges…
Northwell experts update brain cancer biotechnology
By GREGORY ZELLER // A Northwell Health inner circle with deep biotechnology roots has issued a “comprehensive update” of breakthroughs in brain tumor research. The roadmap of next-generation advances in…
Albany backs NYIT’s next-gen bioengineering lab
By GREGORY ZELLER // A new bioengineering laboratory is coming to the New York Institute of Technology’s Old Westbury campus, thanks to a hefty state award. The Empire State Development…